☆ 4.7 Article

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer

BIOMEDICINES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Radiology, Nuclear Medicine & Medical Imaging

PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0

Wolfgang P. Fendler et al.

Summary: This article aims to provide updated guidance and standards for the use of PSMA PET/CT in imaging prostate cancer. It discusses procedures and characteristics of various PSMA small radioligands and different clinical scenarios for their use. The document is intended to support clinicians and technicians in implementing PSMA PET/CT imaging in both research and routine practice.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

添加到收藏夹

Article Oncology

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death

Derya Tilki et al.

Summary: A study found that initiating salvage radiation therapy (sRT) after prostate-specific antigen (PSA) failure above a PSA level of 0.25 ng/mL is associated with an increased risk of all-cause mortality (ACM) among patients with at most one high-risk factor.

JOURNAL OF CLINICAL ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy

Sara Harsini et al.

Summary: This study examines the value of PSMA PET/CT-informed surgery and radiotherapy (RT) in patients with biochemical recurrence (BCR) treated without systemic therapy. The results suggest that RT or surgery based on PSMA PET/CT are associated with high PSA response rates. Further studies are needed to assess the impact of targeting these sites on patient relevant outcomes.

CANCER IMAGING (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study

Justin Ferdinandus et al.

Summary: The European Association of Urology recommends risk groups to identify high-risk prostate cancer patients, and PSMA PET imaging plays an important role in prostate cancer staging.

JOURNAL OF NUCLEAR MEDICINE (2022)

添加到收藏夹

Article Urology & Nephrology

Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups

Matthew J. Roberts et al.

Summary: In patients with post-RP BCR, PSMA-PET findings and receipt of SRT predict event-free survival (EFS). Among patients receiving SRT, PSMA status combined with EAU risk grouping is the most predictive of EFS.

BJU INTERNATIONAL (2022)

添加到收藏夹

Article Oncology

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial

J. Janssen et al.

Summary: This phase III randomized controlled trial aims to assess the potential benefits of adding 6 months of ADT to MDRT in oligo-recurrent PCa patients, in order to improve metastases progression-free survival, toxicity, quality of life, and overall survival.

BMC CANCER (2022)

添加到收藏夹

Article Oncology

Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol

F. H. E. Staal et al.

Summary: The PERYTON trial aims to investigate whether increasing the biological effective radiation dose using hypofractionation can improve the treatment outcome of salvage external beam radiotherapy (sEBRT) for patients with biochemical recurrence (BCR) after radical prostatectomy. The use of PSMA PET/CT allows the exclusion of patients with oligometastases, avoiding ineffective treatment and unnecessary toxicity.

BMC CANCER (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

Liang Dong et al.

Summary: This study evaluated the association between a new biochemical recurrence risk stratification system and PSMA-targeted PET/CT findings. High-risk BCR patients had a higher positive rate on PSMA PET/CT scans, and they were independent predictors of positive scan results. The combination of BCR risk group and prostate-specific antigen showed a higher area under the curve compared to using prostate-specific antigen alone.

JOURNAL OF NUCLEAR MEDICINE (2022)

添加到收藏夹

Article Oncology

PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer-A Prospective Study of Men with 3 Year Follow Up

Sean Ong et al.

Summary: PSMA PET-CT is an important imaging tool for locating recurrent prostate cancer. In this study, we found that 75% of patients had no change in their treatment plan after 3 years of clinical decision-making based on PSMA PET-CT. This percentage increased to 85% for patients with no suspected cancer on PSMA PET-CT.

CANCERS (2022)

添加到收藏夹

Article Oncology

A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis

Rie von Eyben et al.

Summary: This study analyzed 1216 patients with PSA-only recurrence using [Ga-68]Ga-PSMA-11 PET/CT restaging and proposed a new risk model that significantly predicted overall survival. The study found that restaging PSMA PET/CT markedly predicted the 5-year OS and has potential use for patients with PSA-only recurrence.

CANCERS (2022)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

Validation of the European association of urology biochemical recurrence risk groups after radical prostatectomy in an Asian cohort and suggestions for refinement

Sahyun Pak et al.

Summary: The study validated the prognostic utility of the novel European Urology Association (EAU) biochemical recurrence (BCR) risk groups in an Asian cohort, suggesting that modifications may be necessary to optimize predictive performance.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

添加到收藏夹

Article Oncology

Combining 68Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter Study

Simon Kirste et al.

Summary: In this large cohort study, adding elective radiation therapy to Ga-68-PSMA-PET/CT-guided focal radiotherapy significantly improved biochemical-recurrence-free survival compared to focal radiotherapy alone, with lower toxicity.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy

Bernard H. E. Jansen et al.

Summary: This study reviewed 315 patients who underwent PSMA-PET scans after curative radiotherapy, revealing frequent detection of metastatic PCa even in patients below the Phoenix PSA threshold. This suggests a need for re-evaluation of the current diagnostic criteria for recurrent PCa after radiotherapy.

EUROPEAN UROLOGY ONCOLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations

Thomas Van den Broeck et al.

EUROPEAN UROLOGY FOCUS (2020)

添加到收藏夹

Article Oncology

The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy

Sheliyan Raveenthiran et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2019)

添加到收藏夹

Review Urology & Nephrology

Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review

Thomas Van den Broeck et al.

EUROPEAN UROLOGY (2019)

添加到收藏夹

Article Oncology

Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer

Dirk Bottke et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0

Wolfgang P. Fendler et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

添加到收藏夹

Article Urology & Nephrology

A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score

Jonathan I. Epstein et al.

EUROPEAN UROLOGY (2016)

添加到收藏夹

Article Oncology

Improved Metastasis-Free and Survival Outcomes With Early Salvage Radiotherapy in Men With Detectable Prostate-Specific Antigen After Prostatectomy for Prostate Cancer

Bradley J. Stish et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.